Device for non-invasively detecting genetic abnormalities of mother and embryo
A maternal and embryo technology, applied in the field of non-invasive embryo chromosome aneuploidy and other embryonic genetic abnormalities, can solve the problem of high cost of maternal genetic abnormality DNA detection, and achieve the effect of increasing detection costs and saving costs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] (1) Use the Cell-Free DNA BCT test tube of STRECK Company to collect 5ml of blood from pregnant women at 12 weeks of pregnancy according to the instructions of the corresponding equipment;
[0041] (2) Use the QIAamp Circulating Nucleic Acid Kit kit from Qiagen to extract the free DNA in the plasma according to the corresponding kit instructions,
[0042] (3) Use the KAPA Hyper Prep Kit kit from KAPA Biosystems to build a library for the extracted plasma cell-free DNA according to the corresponding kit instructions,
[0043] (4) Use the SeqCap EZ Human Exome Probes v3.0 DNA capture kit from Nimblegen to enrich the human exon sequences in the DNA library according to the corresponding kit instruction manual,
[0044] (5) Use the Nextseq500 model high-throughput sequencing instrument of Illumina to measure the data of 32G bases on the enriched DNA sequence. The length of the DNA sequence is 150 double-ended lengths,
[0045] (6) 70647 variations were detected from the se...
Embodiment 2
[0052] (1) For the DNA sequence data of Example 1, use the method (4) of the present invention to calculate the DNA content of the embryo, the DNA content of the calculated embryo is 3%, the DNA content of the mother is 97%, and the DNA content of the embryo is within a reasonable range of the average value of the population Inside.
[0053] (2) Calculate the variation of the DNA sequence data obtained in this detection, and find that there are more than 90 defect variations in the DNA, and the abundance of these variations is mostly distributed around 1.5% and 50%. Through the method (3), According to calculations in (6) and (7), more than 30 defective mutations were derived from embryos, and more than 60 were derived from mothers.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com